U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06962670) titled 'Predicting Cancer Risk With Digital and Molecular Markers' on Aug. 23, 2023.
Brief Summary: The goal of this study is to identify new markers to predict the risk of developing cancer, primarily breast cancer. For this purpose, researchers will compare data obtained from cancer patients and healthy individuals. If characteristic differences are identified, e.g. in biomarkers, life style or family history, this may indicate a person's increased risk of developing cancer.
Study Start Date: Sept. 14, 2024
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Lung Cancer
Colorectal Cancer
Gynecologic Cancer
Intervention:
OTHER: Biomate...